Question

Which therapy is now suggested for fluid resuscitation to replace patient losses, including administering PRBCs, plasma, and platelets?

1) Hemodialysis therapy
2) Chemotherapy
3) Hormone therapy
4) Blood product therapy

Answer 1

Blood product therapy is recommended for fluid resuscitation to replace losses with PRBCs, plasma, and platelets, observing blood type compatibility to prevent transfusion reactions.

Step-by-step explanation:

For fluid resuscitation to replace patient losses, including administering PRBCs (packed red blood cells), plasma, and platelets, blood product therapy is suggested. This therapy is crucial when managing patients who have suffered significant blood volume loss through trauma, surgery, or disease. It is essential that blood type matching is observed to prevent hemolytic transfusion reactions, which can be potentially lethal. In situations where type O blood is not immediately available, alternatives like saline solutions and ongoing research into artificial blood substitutes, containing hemoglobin or perfluorocarbon-based oxygen carriers, are being explored. These substitutes aim to deliver oxygen akin to normal erythrocytes, eliminating concerns for blood type incompatibility during field transfusions.